Guru Ownership Trend
Guru Analysis for Indivior Pharmaceuticals, Inc. (INDV)
Indivior Pharmaceuticals, Inc. (INDV), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $42.06 M.
Top institutional holders include Jefferies Group and Cliff Asness.
Institutional sentiment is currently Bearish. This is evidenced by a $353.85 M net outflow during the quarter.
Recent activity highlights Joel Greenblatt who dramatically increased their stake. Conversely, Chuck Royce reduced exposure by 96.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Indivior Pharmaceuticals, Inc. (INDV)
Major holders include Jefferies Group ($15.48 M), Cliff Asness ($9.27 M), Joel Greenblatt ($5.23 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 1.13 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $353.85 M, with 3 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 2 fully exited INDV. The total reported sell value was $360.58 M.
Yes, 1 managers opened new positions in INDV, and 2 increased their existing holdings. The total reported buy value was $6.72 M.